MX2020006856A - Trombina secada por aspersion y metodos de uso y preparacion de trombina secada por aspersion. - Google Patents

Trombina secada por aspersion y metodos de uso y preparacion de trombina secada por aspersion.

Info

Publication number
MX2020006856A
MX2020006856A MX2020006856A MX2020006856A MX2020006856A MX 2020006856 A MX2020006856 A MX 2020006856A MX 2020006856 A MX2020006856 A MX 2020006856A MX 2020006856 A MX2020006856 A MX 2020006856A MX 2020006856 A MX2020006856 A MX 2020006856A
Authority
MX
Mexico
Prior art keywords
methods
spray dried
dried thrombin
thrombin
preparation
Prior art date
Application number
MX2020006856A
Other languages
English (en)
Spanish (es)
Inventor
Alexander Wesley Scott
Paul Jeffrey Sanders
Alyssa Sanders
Adam Christopher Mercer
Original Assignee
Baxter Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Int filed Critical Baxter Int
Publication of MX2020006856A publication Critical patent/MX2020006856A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0028—Polypeptides; Proteins; Degradation products thereof
    • A61L26/0047—Specific proteins or polypeptides not covered by groups A61L26/0033 - A61L26/0042
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0031—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/104—Gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/108—Specific proteins or polypeptides not covered by groups A61L24/102 - A61L24/106
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/008—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Surgery (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MX2020006856A 2017-12-29 2018-12-20 Trombina secada por aspersion y metodos de uso y preparacion de trombina secada por aspersion. MX2020006856A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762611963P 2017-12-29 2017-12-29
US201862771936P 2018-11-27 2018-11-27
PCT/US2018/066838 WO2019133440A1 (en) 2017-12-29 2018-12-20 Spray-dried thrombin and methods of using and making spray-dried thrombin

Publications (1)

Publication Number Publication Date
MX2020006856A true MX2020006856A (es) 2020-08-24

Family

ID=65024106

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020006856A MX2020006856A (es) 2017-12-29 2018-12-20 Trombina secada por aspersion y metodos de uso y preparacion de trombina secada por aspersion.

Country Status (12)

Country Link
US (1) US11583610B2 (https=)
EP (1) EP3731885B1 (https=)
JP (1) JP2021508507A (https=)
KR (1) KR20200105680A (https=)
CN (1) CN111787958A (https=)
AU (1) AU2018396037A1 (https=)
BR (1) BR112020011034A2 (https=)
CA (1) CA3083064A1 (https=)
ES (1) ES3058243T3 (https=)
MX (1) MX2020006856A (https=)
SG (1) SG11202005231RA (https=)
WO (1) WO2019133440A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12343385B2 (en) 2021-11-29 2025-07-01 Baxter International Inc. Hemostat reconstitution methods and devices
CN118785918A (zh) 2021-12-23 2024-10-15 广州倍绣生物技术有限公司 喷雾干燥的凝血酶

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7435425B2 (en) 2001-07-17 2008-10-14 Baxter International, Inc. Dry hemostatic compositions and methods for their preparation
US8303981B2 (en) 1996-08-27 2012-11-06 Baxter International Inc. Fragmented polymeric compositions and methods for their use
US6706690B2 (en) 1999-06-10 2004-03-16 Baxter Healthcare Corporation Hemoactive compositions and methods for their manufacture and use
US8603511B2 (en) 1996-08-27 2013-12-10 Baxter International, Inc. Fragmented polymeric compositions and methods for their use
US6066325A (en) 1996-08-27 2000-05-23 Fusion Medical Technologies, Inc. Fragmented polymeric compositions and methods for their use
US6063061A (en) 1996-08-27 2000-05-16 Fusion Medical Technologies, Inc. Fragmented polymeric compositions and methods for their use
US7572769B2 (en) 1998-12-23 2009-08-11 Csl Behring Gmbh Fibrin adhesive granulate and method for its preparation
DE19859611C2 (de) * 1998-12-23 2003-07-03 Aventis Behring Gmbh Fibrinklebergranulat und Verfahren zu dessen Herstellung
ES2682302T3 (es) 2010-06-01 2018-09-19 Baxter International Inc Proceso para la producción de composiciones hemostáticas secas y estables
JP5973997B2 (ja) 2010-06-01 2016-08-23 バクスター・インターナショナル・インコーポレイテッドＢａｘｔｅｒ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｉｎｃｏｒｐ０Ｒａｔｅｄ 乾燥した安定な止血用組成物を作製するためのプロセス
AU2011260260B2 (en) 2010-06-01 2015-09-03 Baxter Healthcare S.A. Process for making dry and stable hemostatic compositions
RU2013155713A (ru) * 2011-07-06 2015-08-20 Профибрикс Бв Составы для лечения ран
IL242984A0 (en) 2015-12-08 2016-02-29 Omrix Biopharmaceuticals Ltd Thrombin microcapsules, their preparation and how to use them
US10159720B2 (en) * 2015-12-08 2018-12-25 Omrix Biopharmaceuticals Ltd Thrombin microcapsules, preparation and uses thereof
CN107754005B (zh) 2016-08-15 2021-06-15 广州倍绣生物技术有限公司 止血组合物及其制造方法

Also Published As

Publication number Publication date
KR20200105680A (ko) 2020-09-08
ES3058243T3 (en) 2026-03-09
BR112020011034A2 (pt) 2020-11-17
SG11202005231RA (en) 2020-07-29
US11583610B2 (en) 2023-02-21
CA3083064A1 (en) 2019-07-04
JP2021508507A (ja) 2021-03-11
CN111787958A (zh) 2020-10-16
WO2019133440A1 (en) 2019-07-04
AU2018396037A1 (en) 2020-06-18
EP3731885A1 (en) 2020-11-04
US20210379240A1 (en) 2021-12-09
EP3731885B1 (en) 2025-10-08

Similar Documents

Publication Publication Date Title
CL2023002345A1 (es) Composiciones y métodos para fabricar microparticulas de proteína.
CR20190063A (es) 3-metil pirazinas 2,5-disustituídas y 3-metil pirazinas 2,5,6-trisustituídas como inhibidores alostéricos de shp2
MX2021015936A (es) Metodos para preparar acido bempedoico y composiciones del mismo.
SV2018005610A (es) Derivados de oxopiridina sustituidos
MX2018015749A (es) Formulacion de una vacuna peptidica.
MX2018002990A (es) Uso de la akkermansia pasteurizada para tratar trastornos metabolicos.
TWD179994S (zh) 鞋子
MX2016005031A (es) Agentes de consolidacion con resistencia mejorada.
MX372956B (es) Novedosas cepas de lactobacillus y los usos de las mismas.
UY37081A (es) Derivados de heterociclos bicíclicos condensados como pesticidas
MX374129B (es) Proceso para la preparación de eritrocitos cargados con una o más sustancias de interés farmacéutico y eritrocitos así obtenidos.
MX2017013739A (es) Vendaje para heridas.
MX2017014563A (es) Aplicador de spray de intervalo extendido.
MX378866B (es) Composiciones de azucar para la formacion de comprimidos por compresion directa.
MX2017012595A (es) Un extracto de indigo naturalis y un proceso para preparar el mismo.
MX2016010328A (es) Tratamiento con halogeno de ataque cardiaco y lesion isquemica.
UY37365A (es) Derivados de heterociclos bicíclicos condensados como pesticidas
CO2017002506A2 (es) Nuevos activadores de la guanilato ciclasa soluble y su uso
MX392182B (es) Combinaciones de dosis fija y formulaciones que comprenden ácido 8-hidroxi-2,2,14,14 tetrametilpentadecanodioico (etc1002) y ezetimiba y métodos para tratar o reducir el riesgo de enfermedad cardiovascular.
BR112015021218A2 (pt) nova formulação de aditivos, produção e utilização da mesma
CL2018001104A1 (es) Composición para el cuidado de la piel y procedimiento asociado.
CR20150653A (es) Compuestos nuevos para el tratamiento del cáncer
MX2018015872A (es) Derivados de benzodioxano y su uso farmaceutico.
MX389438B (es) Granulos de manitol para compresion directa.
MX2020006856A (es) Trombina secada por aspersion y metodos de uso y preparacion de trombina secada por aspersion.